Wolff Wiese Magana’s Charles River Laboratories CRL Stock Holding History

Wolff Wiese Magana’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-39	Closed	-$5.92K	–	981
2025 Q2	$5.92K	Sell	39 -44	-53%	-$5.87K	﹤0.01%	527
2025 Q1	$12.5K	Sell	83 -79	-49%	-$13.2K	0.01%	369
2024 Q4	$29.9K	Hold	162	–	–	0.02%	248
2024 Q3	$31.9K	Buy	+162	New	+$33.7K	0.02%	241
2022 Q4	–	Sell	-319	Closed	-$63K	–	816
2022 Q3	$63K	Buy	319 +20	+7%	+$4.32K	0.05%	208
2022 Q2	$64K	Buy	299 +41	+16%	+$10K	0.05%	218
2022 Q1	$73K	Buy	258 +34	+15%	+$10.5K	0.05%	219
2021 Q4	$84K	Buy	224 +121	+117%	+$47K	0.05%	219
2021 Q3	$42K	Buy	103 +56	+119%	+$23.3K	0.03%	307
2021 Q2	$18K	Buy	47 +28	+147%	+$9.35K	0.01%	409
2021 Q1	$6K	Hold	19	–	–	﹤0.01%	558
2020 Q4	$5K	Buy	+19	New	+$4.53K	﹤0.01%	527

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wolff Wiese Magana's CRL Position: Q3 2025 in Review

Wolff Wiese Magana sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 39 shares — an estimated $5.92K sold.

Wolff Wiese Magana first reported a position in CRL in Q4 2020 and held it in 12 quarters. The position peaked at $84K in Q4 2021. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

Wolff Wiese Magana reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
Wolff Wiese Magana sold 39 Charles River Laboratories shares in Q3 2025, an estimated $5.92K.
Wolff Wiese Magana first reported a position in Charles River Laboratories in Q4 2020 and held it in 12 quarters.
Wolff Wiese Magana's Charles River Laboratories position peaked at $84K in Q4 2021.
556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Wolff Wiese Magana's 13F filing for Q3 2025, filed 28 Oct 2025.